Fifth Vioxx Victory Bodes Well For Merck

Law360, New York (August 3, 2006, 12:00 AM EDT) -- A California court has ruled in favor of Merck & Co. in the first Vioxx case to go to trial in the state, marking the second victory for the pharmaceutical company in as many months.

After five hours of deliberation, a jury ruled that the arthritis treatment was not the cause of plaintiff Stewart Grossberg’s 2001 heart attack, agreeing with the defense that Grossberg’s other medical problems, including high cholesterol levels, atherosclerosis and a family history of cardiac problems, contributed more to the attack than his...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.